After approving Bavarian Nordic’s mpox vaccine in September for use in adults, the World Health Organisation has given the vaccine the green light for use in adolescents aged 12 to 17 years. It comes as parts of Africa attempt to contain an uptick in cases of the disease.
Tags
There’s no content to show here yet.
Latest Stories
- Deschamps defends Mbappe amid rape accusation and ‘fake news’ controversy
- Protesters in eastern DRC denounce Rwanda and rebel negotiations
- Beninese anti-French activist Kemi Seba arrested in Paris
- ICC prosecutor announces renewed probe into alleged crimes in eastern Congo
- UN: Southern Africa faces worst hunger crisis in decades due to El Niño
- DRC cancels auction of 27 oil blocks
- Over 2 million displaced, 200 communities submerged as floods ravage Kogi, Nigeria
- Chief Justice Koome names judges to handle DP Gachagua ouster petitions
- Italy transfers first group of asylum seekers to Albania as part of controversial deal
- World Food Forum opens with call to build inclusive agrifood systems
Recent Comments
No comments to show.
Leave a Reply